Search Results - "ALANEN, K"

Refine Results
  1. 1

    Alpha-smooth muscle actin within epithelial islands is predictive of ameloblastic carcinoma by Bello, I.O, Alanen, K, Slootweg, P.J, Salo, T

    Published in Oral oncology (01-09-2009)
    “…Summary Ameloblastoma is the most common clinically significant odontogenic tumor. It is considered benign but locally invasive and associated with variable…”
    Get full text
    Journal Article
  2. 2

    Mannose receptor is a novel ligand for L-selectin and mediates lymphocyte binding to lymphatic endothelium by Irjala, H, Johansson, E L, Grenman, R, Alanen, K, Salmi, M, Jalkanen, S

    Published in The Journal of experimental medicine (15-10-2001)
    “…Continuous lymphocyte recirculation between blood and lymphoid tissues forms a basis for the function of the immune system. Lymphocyte entrance from the blood…”
    Get full text
    Journal Article
  3. 3

    Severe periprosthetic osteolytic lesions after the Ankle Evolutive System total ankle replacement by KOIVU, H, KOHONEN, I, SIPOLA, E, ALANEN, K, VAHLBERG, T, TIUSANEN, H

    “…Between 2002 and 2008, 130 consecutive ankles were replaced with an hydroxyapatite (HA) and titanium-HA-coated Ankle Evolutive System total ankle prosthesis…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Augmented expression of endothelin-1, endothelin-3 and the endothelin-B receptor in breast carcinoma by ALANEN, K, DENG, D.-X, CHAKRABARTI, S

    Published in Histopathology (01-02-2000)
    “…Aims Endothelins (ETs) are peptides expressed in many tumours which may stimulate angiogenesis and desmoplasia. Because ETs have not been extensively studied…”
    Get full text
    Journal Article
  6. 6

    Group II phospholipase A2 in human male reproductive organs and genital tumors by Kallajoki, M., Alanen, K.A., Nevalainen, M., Nevalainen, T.J.

    Published in The Prostate (01-06-1998)
    “…BACKGROUND Group II phospholipase A2 (PLA2) is a lipolytic enzyme suggested to play a role in inflammation and antibacterial defence. In seminal fluid, the…”
    Get full text
    Journal Article
  7. 7

    Assessment of cytologic follow‐up as the recommended management for patients with atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions by Alanen, Ken W., Elit, Laurie M., Molinaro, Patricia A., McLachlin, Catherine M.

    Published in Cancer (25-02-1998)
    “…BACKGROUND The optimal management of low grade Papanicolaou (Pap) smear abnormalities remains controversial. This center's experience with recommending…”
    Get full text
    Journal Article
  8. 8

    Gene expression of group II phospholipase A2 in intestine in Crohn's disease by HAAPAMÄKI, M. M, GRÖNROOS, J. M, NURMI, H, ALANEN, K, NEVALAINEN, T. J

    Published in The American journal of gastroenterology (01-03-1999)
    “…Phospholipase A2 (PLA2) has been suggested to play an important role in the pathogenesis of inflammatory bowel diseases. Our aim was to identify cells that…”
    Get full text
    Journal Article
  9. 9

    Gene expression of group II phospholipase A2 in intestine in ulcerative colitis by Haapamäki, M M, Grönroos, J M, Nurmi, H, Alanen, K, Kallajoki, M, Nevalainen, T J

    Published in Gut (01-01-1997)
    “…BACKGROUND: It has been suggested that phospholipase A2 (PLA2) has an essential role in the pathogenesis of inflammatory bowel diseases. AIMS: This study aimed…”
    Get full text
    Journal Article
  10. 10

    Prevalence of the C282Y mutation of the hemochromatosis gene in liver transplant recipients and donors by Alanen, Kenneth W., Chakrabarti, Subrata, Rawlins, Jenna J., Howson, William, Jeffrey, Gary, Adams, Paul C.

    Published in Hepatology (Baltimore, Md.) (01-09-1999)
    “…Hemochromatosis heterozygotes may be predisposed to end‐stage liver disease from other causes. The aims of this study were to determine the prevalence of the…”
    Get full text
    Journal Article
  11. 11

    Long-term survival after pancreatic adenocarcinoma - often a misdiagnosis? by ALANEN, K. A, JOENSUU, H

    Published in British journal of cancer (01-11-1993)
    “…Prognosis of adenocarcinoma of the pancreas has remained poor, but a few patients are reported to live 5 years or longer after the diagnosis. Using the data of…”
    Get full text
    Journal Article
  12. 12

    Transplantation of haemochromatosis liver and intestine into a normal recipient by ADAMS, P C, JEFFREY, G, ALANEN, K, CHAKRABARTI, S, PRESHAW, R, HOWSON, W, GRANT, D

    Published in Gut (01-11-1999)
    “…[...]we have identified a predisposition to future iron overload rather than iron overload at 21 months…”
    Get full text
    Journal Article
  13. 13

    Phospholipase A2 in serum and colonic mucosa in ulcerative colitis by HAAPAMÄKI, M. M, GRÖNROOS, J. M, NURMI, H, IRJALA, K, ALANEN, K. A, NEVALAINEN, T. J

    “…Group II phospholipase A2 is involved in the pathogenesis of various inflammatory diseases and in the host defence against bacteria. The enzyme is expressed in…”
    Get full text
    Journal Article
  14. 14

    Immunohistochemical labelling for prostate-specific antigen in breast carcinomas by ALANEN, K. A, KUOPIO, T, COLLAN, Y. U, KRONQVIST, P, JUNTTI, L, NEVALAINEN, T. J

    Published in Breast cancer research and treatment (01-07-1999)
    “…Immunohistochemical detection of prostate-specific antigen (PSA) is an aid in determining the prostatic origin of metastatic cells. However, small amounts of…”
    Get full text
    Journal Article
  15. 15

    Cyclin A and Ki-67 with DNA content in benign and malignant prostatic epithelial lesions by Mirtti, T, Kallajoki, M, Aaltonen, M, Alanen, K

    “…To evaluate the usefulness of immunohistochemical staining of cyclin A and Ki-67 together with DNA content in the classification of benign prostatic…”
    Get more information
    Journal Article
  16. 16

    Stat3 Promotes Metastatic Progression of Prostate Cancer by Abdulghani, Junaid, Gu, Lei, Dagvadorj, Ayush, Lutz, Jacqueline, Leiby, Benjamin, Bonuccelli, Gloria, Lisanti, Michael P, Zellweger, Tobias, Alanen, Kalle, Mirtti, Tuomas, Visakorpi, Tapio, Bubendorf, Lukas, Nevalainen, Marja T

    Published in The American journal of pathology (01-06-2008)
    “…There are currently no effective therapies for metastatic prostate cancer because the molecular mechanisms that underlie the metastatic spread of primary…”
    Get full text
    Journal Article
  17. 17

    Immunohistochemical Labelling for Prostate Specific Antigen in Non-Prostatic Tissues by Alanen, K.A., Kuopio, T., Koskinen, P.J., Nevalainen, T.J.

    Published in Pathology, research and practice (01-03-1996)
    “…Immunohistochemical detection of prostate specific antigen (PSA) in metastases of adenocarcinomas is widely used as an aid to identify the prostatic origin of…”
    Get full text
    Journal Article
  18. 18

    Imaging of Uterine Carcinoma by Carbon-11-Methionine and PET by Lapela, Maria, Leskinen-Kallio, Sirkku, Varpula, Matti, Grenman, Seija, Alanen, Kalle, Nagren, Kjell, Lehikoinen, Pertti, Ruotsalainen, Ulla, Teras, Mika, Joensuu, Heikki

    Published in The Journal of nuclear medicine (1978) (01-10-1994)
    “…L-[methyl-11C]methionine ([11C]methionine) is probably one of the most useful positron-emitting tracers for metabolic imaging of human cancer. In this study,…”
    Get full text
    Journal Article
  19. 19

    Metabolic Imaging of Ovarian Tumors with Carbon-11-Methionine: A PET Study by Lapela, Maria, Leskinen-Kallio, Sirkku, Varpula, Matti, Grenman, Seija, Salmi, Tuula, Alanen, Kalle, Nagren, Kjell, Lehikoinen, Pertti, Ruotsalainen, Ulla, Teras, Mika, Joensuu, Heikki

    Published in The Journal of nuclear medicine (1978) (01-12-1995)
    “…This study examines the potential of 11C-methionine as a PET tracer in metabolic imaging of benign and malignant ovarian tumors. Four patients with one or two…”
    Get full text
    Journal Article
  20. 20

    Proliferating cell nuclear antigen (PCNA) as a prognostic factor in non-Hodgkin's lymphoma by KLEMI, P. J, ALANEN, K, JALKANEN, S, JOENSUU, H

    Published in British journal of cancer (01-10-1992)
    “…The prognostic value of immunoperoxidase staining for proliferating cell nuclear antigen (PCNA) was studied in a series of 140 non-Hodgkin's lymphomas with…”
    Get full text
    Journal Article